This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Sep;25(7):491-500.

doi: 10.1007/s00296-005-0585-y. Epub 2005 Jun 29.

Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients

Irena Adamashvili¹, Roger E Kelley, Thomas Pressly, John C McDonald

Affiliations

PMID: 15986087
DOI: 10.1007/s00296-005-0585-y

Review

Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients

Irena Adamashvili et al. Rheumatol Int. 2005 Sep.

. 2005 Sep;25(7):491-500.

doi: 10.1007/s00296-005-0585-y. Epub 2005 Jun 29.

Authors

Irena Adamashvili¹, Roger E Kelley, Thomas Pressly, John C McDonald

Affiliation

¹ Department of Neurology, Louisiana State University Medical Center, P.O. Box 33932, Shreveport, LA 71130, USA. iadama@lsuhsc.edu

PMID: 15986087
DOI: 10.1007/s00296-005-0585-y

No abstract available

PubMed Disclaimer

Similar articles

Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients.
Billing H, Sander A, Süsal C, Ovens J, Feneberg R, Höcker B, Vondrak K, Grenda R, Friman S, Milford DV, Lucan M, Opelz G, Tönshoff B. Billing H, et al. Transpl Int. 2013 Mar;26(3):331-8. doi: 10.1111/tri.12049. Epub 2012 Dec 31. Transpl Int. 2013. PMID: 23279372 Clinical Trial.
A complementary strategy for pretransplant HLA antibody screening.
Tiercy JM, Cattin S, Pongratz G, Goumaz C, Villard J. Tiercy JM, et al. Transplant Proc. 2002 May;34(3):850-1. doi: 10.1016/s0041-1345(02)02685-4. Transplant Proc. 2002. PMID: 12034207 No abstract available.
Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine E, Berthoux F, Acquart S, Lepetit JC. Alamartine E, et al. Transplant Proc. 1992 Dec;24(6):2461-2. Transplant Proc. 1992. PMID: 1465831 No abstract available.
Mechanisms of allorecognition and organ transplant rejection.
Slavcev A. Slavcev A. Ann Transplant. 2001;6(4):5-8. Ann Transplant. 2001. PMID: 12035460 Review.
Variable expression of major histocompatibility antigens: role in transplantation immunology.
Koene RA, de Waal RM, Bogman MJ. Koene RA, et al. Kidney Int. 1986 Jul;30(1):1-8. doi: 10.1038/ki.1986.142. Kidney Int. 1986. PMID: 2427768 Review. No abstract available.

See all similar articles

Cited by

Soluble HLA revisited.
Tabayoyong WB, Zavazava N. Tabayoyong WB, et al. Leuk Res. 2007 Feb;31(2):121-5. doi: 10.1016/j.leukres.2006.06.008. Epub 2006 Jul 24. Leuk Res. 2007. PMID: 16860865 Free PMC article. Review.
Salivary biomarkers for the diagnosis and monitoring of neurological diseases.
Farah R, Haraty H, Salame Z, Fares Y, Ojcius DM, Said Sadier N. Farah R, et al. Biomed J. 2018 Apr;41(2):63-87. doi: 10.1016/j.bj.2018.03.004. Epub 2018 May 10. Biomed J. 2018. PMID: 29866603 Free PMC article. Review.
Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.
Pizzi M, Boi M, Bertoni F, Inghirami G. Pizzi M, et al. Leukemia. 2016 Sep;30(9):1805-15. doi: 10.1038/leu.2016.161. Epub 2016 Jun 8. Leukemia. 2016. PMID: 27389058 Review.
Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum.
Won DI, Lee NY, Lim JH, Han YS, Kim CD, Huh S. Won DI, et al. Blood Res. 2020 Jun 30;55(2):91-98. doi: 10.5045/br.2020.2020031. Blood Res. 2020. PMID: 32429622 Free PMC article.

References

1. Transplantation. 1973 Sep;16(3):205-10 - PubMed
1. J Immunol Methods. 1986 Feb 12;86(2):187-90 - PubMed
1. Vox Sang. 1995;68(2):73-6 - PubMed
1. Immunogenetics. 1988;27(3):203-10 - PubMed
1. Hum Immunol. 1988 Mar;21(3):193-207 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program